Wrapping up its third year, FAST: Functional Analysis & Screening Technologies Congress was host to 250+ Drug R&D teams dedicated to improving drug screening and safety using 3D cell culture, phenotypic screening, and cancer immunotherapy. Cambridge Healthtech Institute (CHI) would like to thank all the speakers, attendees, sponsors, and exhibitors for their participation.

2015 Event Stats:

• 250+ Delegates from 130+ Companies
• 60 Speakers
• 25 Posters Presented
• 15 Countries Represented
• 14 Exhibiting Companies

View the 2015 Attendee List

>Here’s what our attendees had to say about the congress:

If you missed our 2015 event, you can reserve a copy of the conference proceedings CD to access the speaker slides and poster abstracts our delegates received on-site.

 Dinner Short Courses:

• Introduction to High-Content Phenotypic Screening
• Screening Strategies for Cancer Immunotherapy
• Expert ThinkTank: How to Meet the Need for Physiologically Relevant Assays

Coverage Includes:

• Organoids and Primary Organotypic 3D Culture in Drug Discovery
• Phenotypic Screening for New Target, Pathway and Mechanism-of-Action Discovery
• Phenotypic Screening Using Primary and Stem Cell-Derived Models
• Case Studies in Phenotypic Drug Discovery
• Engineering Functional Organ-on-a-Chip Models
• 3D Spheroid Models for Drug Screening
• Integrated Approach to in vitro Drug Discovery: Tissue Engineering Meets Systems Biology
• Microengineered 3D Models for Drug Safety Testing
• Phenotypic and High-Content Screening of 3D Models
• Cancer-on-a-Chip: Engineering 3D Models of Tumor Microenvironment

Featured Speakers: